Seneca Therapeutics

Blue Bell, PA · Founded 2018 · Privately Held (backing)

Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. Seneca Therapeutics is based in Blue Bell, PA and was founded in 2018. It was valued at $51 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $25.2 million across 5 recorded rounds; the latest was a $1.6 million seed round in Dec 2024.

PMV mark · valuation
$51.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$25.2M
Last round
Seed Round
Dec 2024

Who backs Seneca Therapeutics?

14 investors
InvestorType
Keiretsu ForumOther
Denniston Family OfficeFamily office
Accelerator Venture Partners—
Broad Street Angels—
Charmides Capital—
Dellin Investments—
Keiretsu Capital—
Mid Atlantic Bio Angels—
Minnow Venture Partners—
NW Angel—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Seneca Therapeutics investors

14 investors are on record for Seneca Therapeutics, including Keiretsu Forum, Denniston Family Office, Accelerator Venture Partners and Broad Street Angels. The seed round in Dec 2024 drew 68 investors.

Free account
More of Seneca Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Seneca Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Seneca Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View